[PHARMA] QoQ Annualized Quarter Result on 30-Sep-2009 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
13-Nov-2009
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2009
Quarter
30-Sep-2009 [#3]
Profit Trend
QoQ- -20.79%
YoY- -9.38%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
Revenue 1,335,790 1,270,240 1,300,796 1,302,520 1,293,856 1,254,864 1,305,646 1.53%
PBT 65,516 49,724 81,436 71,930 89,042 80,736 90,599 -19.48%
Tax -17,862 -12,488 -19,709 -19,116 -22,610 -21,964 -29,190 -27.98%
NP 47,654 37,236 61,727 52,814 66,432 58,772 61,409 -15.59%
-
NP to SH 48,108 37,228 60,191 51,038 64,438 58,088 60,031 -13.75%
-
Tax Rate 27.26% 25.11% 24.20% 26.58% 25.39% 27.20% 32.22% -
Total Cost 1,288,136 1,233,004 1,239,069 1,249,705 1,227,424 1,196,092 1,244,237 2.34%
-
Net Worth 417,306 439,675 431,158 407,610 400,063 402,378 388,297 4.93%
Dividend
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
Div 100,581 - 39,585 38,514 57,763 - 28,881 130.28%
Div Payout % 209.07% - 65.77% 75.46% 89.64% - 48.11% -
Equity
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
Net Worth 417,306 439,675 431,158 407,610 400,063 402,378 388,297 4.93%
NOSH 107,001 106,977 106,987 106,984 106,968 107,015 106,968 0.02%
Ratio Analysis
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
NP Margin 3.57% 2.93% 4.75% 4.05% 5.13% 4.68% 4.70% -
ROE 11.53% 8.47% 13.96% 12.52% 16.11% 14.44% 15.46% -
Per Share
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
RPS 1,248.38 1,187.40 1,215.84 1,217.49 1,209.56 1,172.60 1,220.58 1.51%
EPS 44.96 34.80 56.26 47.71 60.24 54.28 56.12 -13.77%
DPS 94.00 0.00 37.00 36.00 54.00 0.00 27.00 130.23%
NAPS 3.90 4.11 4.03 3.81 3.74 3.76 3.63 4.91%
Adjusted Per Share Value based on latest NOSH - 107,049
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
RPS 92.68 88.13 90.25 90.37 89.77 87.07 90.59 1.53%
EPS 3.34 2.58 4.18 3.54 4.47 4.03 4.17 -13.78%
DPS 6.98 0.00 2.75 2.67 4.01 0.00 2.00 130.60%
NAPS 0.2895 0.3051 0.2992 0.2828 0.2776 0.2792 0.2694 4.92%
Price Multiplier on Financial Quarter End Date
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
Date 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 -
Price 4.98 4.27 4.00 4.09 3.80 3.45 3.36 -
P/RPS 0.40 0.36 0.33 0.34 0.31 0.29 0.28 26.92%
P/EPS 11.08 12.27 7.11 8.57 6.31 6.36 5.99 50.85%
EY 9.03 8.15 14.07 11.66 15.85 15.73 16.70 -33.70%
DY 18.88 0.00 9.25 8.80 14.21 0.00 8.04 76.94%
P/NAPS 1.28 1.04 0.99 1.07 1.02 0.92 0.93 23.80%
Price Multiplier on Announcement Date
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
Date 11/08/10 26/05/10 19/02/10 13/11/09 21/08/09 08/05/09 27/02/09 -
Price 4.95 4.71 4.05 3.93 4.00 3.82 2.73 -
P/RPS 0.40 0.40 0.33 0.32 0.33 0.33 0.22 49.13%
P/EPS 11.01 13.53 7.20 8.24 6.64 7.04 4.86 72.74%
EY 9.08 7.39 13.89 12.14 15.06 14.21 20.56 -42.09%
DY 18.99 0.00 9.14 9.16 13.50 0.00 9.89 54.66%
P/NAPS 1.27 1.15 1.00 1.03 1.07 1.02 0.75 42.20%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment